BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37081678)

  • 1. Biologic Therapies Targeting Eosinophilic Gastrointestinal Diseases.
    Oshima T
    Intern Med; 2023 Dec; 62(23):3429-3430. PubMed ID: 37081678
    [No Abstract]   [Full Text] [Related]  

  • 2. Biological therapies for eosinophilic gastrointestinal diseases.
    Wechsler JB; Hirano I
    J Allergy Clin Immunol; 2018 Jul; 142(1):24-31.e2. PubMed ID: 29859203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The New Therapeutic Frontiers in the Treatment of Eosinophilic Esophagitis: Biological Drugs.
    Ridolo E; Barone A; Ottoni M; Peveri S; Montagni M; Nicoletta F
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologics in eosinophilic gastrointestinal diseases.
    Dellon ES; Spergel JM
    Ann Allergy Asthma Immunol; 2023 Jan; 130(1):21-27. PubMed ID: 35738437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophilic gastroenteritis presenting as achalasia cardia and responding to botulinum injection and therapy directed against eosinophilic esophagitis.
    Mathur A; Mundada K; Verma A; Agrawal V; Verma V; Ghoshal UC
    Indian J Gastroenterol; 2019 Dec; 38(6):554-556. PubMed ID: 31950436
    [No Abstract]   [Full Text] [Related]  

  • 6. Eosinophilic Gastrointestinal Disorders.
    Fahey LM; Liacouras CA
    Pediatr Clin North Am; 2017 Jun; 64(3):475-485. PubMed ID: 28502433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton pump inhibitor treatment decreased duodenal and esophageal eosinophilia in a case of eosinophilic gastroenteritis.
    Yamada Y; Toki F; Yamamoto H; Nishi A; Kato M
    Allergol Int; 2015 Sep; 64 Suppl():S83-5. PubMed ID: 26344087
    [No Abstract]   [Full Text] [Related]  

  • 8. Emerging Therapies for Eosinophilic Gastrointestinal Diseases.
    Peterson K; Safroneeva E; Schoepfer A
    J Allergy Clin Immunol Pract; 2021 Sep; 9(9):3276-3281. PubMed ID: 34343695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologics in Eosinophilic Gastrointestinal Disease Treatment: A new frontier.
    Greenhawt M
    Ann Allergy Asthma Immunol; 2023 Feb; 130(2):155-156. PubMed ID: 36737159
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacological treatment of eosinophilic gastrointestinal disorders.
    Hua S; Cook D; Walker MM; Talley NJ
    Expert Rev Clin Pharmacol; 2016 Sep; 9(9):1195-209. PubMed ID: 27191032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic Management of Eosinophilic Esophagitis.
    Falk GW; Pesek R
    Immunol Allergy Clin North Am; 2024 May; 44(2):245-264. PubMed ID: 38575221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted Therapies for Eosinophilic Gastrointestinal Disorders.
    Lucendo AJ; López-Sánchez P
    BioDrugs; 2020 Aug; 34(4):477-493. PubMed ID: 32472465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Eosinophilic gastrointestinal disease - a rare condition of unknown cause].
    Melas N
    Lakartidningen; 2022 Apr; 119():. PubMed ID: 35403208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe asthma with eosinophilic gastroenteritis effectively managed by mepolizumab and omalizumab.
    Han D; Lee JK
    Ann Allergy Asthma Immunol; 2018 Dec; 121(6):742-743. PubMed ID: 30056148
    [No Abstract]   [Full Text] [Related]  

  • 15. Recent Progress in the Research of Eosinophilic Esophagitis and Gastroenteritis.
    Kinoshita Y; Ishimura N; Oshima N; Mikami H; Okimoto E; Jiao DJ; Ishihara S
    Digestion; 2016; 93(1):7-12. PubMed ID: 26789117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics of Japanese patients with eosinophilic esophagitis and eosinophilic gastroenteritis.
    Kinoshita Y; Furuta K; Ishimaura N; Ishihara S; Sato S; Maruyama R; Ohara S; Matsumoto T; Sakamoto C; Matsui T; Ishikawa S; Chiba T
    J Gastroenterol; 2013 Mar; 48(3):333-9. PubMed ID: 22847555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A new nomencaluture for eosinophilic gastrointestinal diseases].
    von Arnim U
    MMW Fortschr Med; 2023 Apr; 165(8):55-56. PubMed ID: 37081357
    [No Abstract]   [Full Text] [Related]  

  • 18. Impressions and aspirations from the FDA GREAT VI Workshop on Eosinophilic Gastrointestinal Disorders Beyond Eosinophilic Esophagitis and Perspectives for Progress in the Field.
    Rothenberg ME; Hottinger SKB; Gonsalves N; Furuta GT; Collins MH; Talley NJ; Peterson K; Menard-Katcher C; Smith M; Hirano I; Genta RM; Chehade M; Gupta SK; Spergel JM; Aceves SS; Dellon ES
    J Allergy Clin Immunol; 2022 Mar; 149(3):844-853. PubMed ID: 34953790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologics in Eosinophilic Esophagitis - Ready for Prime Time?
    Straumann A
    N Engl J Med; 2022 Dec; 387(25):2379-2380. PubMed ID: 36546632
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnosis, Natural History and Treatment of Eosinophilic Enteritis: a Review.
    Pineton de Chambrun G; Dufour G; Tassy B; Rivière B; Bouta N; Bismuth M; Panaro F; Funakoshi N; Ramos J; Valats JC; Blanc P
    Curr Gastroenterol Rep; 2018 Jul; 20(8):37. PubMed ID: 29968127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.